Countries Hongkong

AI+ Media Development Platform AlfaOPA™ Officially Launched

At the summit, Great Bay Bio announced the official launch of its self-developed AI-enabled, no-screening culture media development platform, AlfaOPA&trade...

 August 04, 2023 | News

JinMed's Nanobathing Products Earn Patents, Secure Procurement Deal with Shanghai Zhongjin HongKang Medical Technology

Currently, the Company's nanobathing products have been granted an invention patent and four utility model patents. Among them, one medical nanobathing car...

 August 04, 2023 | News

Alma Veil™ Launched for U.S. Market by Sisram Medical's Alma

Alma Veil is the core instrument equipped with three gold-standard technologies conveniently integrated into a single handpiece: 532 nm laser:...

 July 26, 2023 | News

Insilico Medicine Nominates Preclinical Candidate for ISM001-055, First Generative AI IPF Drug

  Insilico Medicine merges nebulizer device with AI-driven drug discovery; Potential advantages for the inhalation solution include a smaller effe...

 July 24, 2023 | News

BGI Genomics Global Cervical Cancer Survey Finds Young Women Have Higher Vaccination Rates but 43.5 percent Put off by Pap Smears

 To further inform action to combat cervical cancer, the fourth most common cancer among women globally, BGI Genomics released its State of Cervi...

 July 24, 2023 | News

Antengene Administers First Patient in US Clinical Study of ATG-017 for Advanced Solid Tumors with Nivolumab Combination

-  ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop...

 July 18, 2023 | News

Antengene's XPOVIO® Approved in Hong Kong for Relapsed Multiple Myeloma

XPOVIO® has received regulatory approvals in 41 countries and regions including the United States, Israel, the United Kingdo...

 July 17, 2023 | News

Sirnaomics Forms Strategic Partnership with EDIRNA Inc. in RNA-Editing Therapeutics

EDIRNA is a start-up biotech company focusing on RNA-Editing therapeutics and taking advantage of the Group's proprietary technology platforms for novel RN...

 July 06, 2023 | News

Gilead Sciences and IAS Honor Global Healthcare Providers for Stigma-Free HIV Services

The 2023 Me and My Healthcare Provider (MMHCP) campaign, supported by Gilead for the second year running, honours frontline workers providing exemplary inc...

 July 05, 2023 | News

AI-Designed Drug Enters Phase II Trials, First Patients Dosed by Insilico Medicine

  After completing the Phase 0 and Phase I human safety studies, INS018_055, Insilico's AI-discovered and AI-generated drug, has ent...

 June 28, 2023 | News

Hong Kong Polytechnic University researchers develop Optoelectronic Graded Neurons

he tiny visual systems of flying insects have inspired researchers of the Hong Kong Polytechnic University (PolyU) to develop Optoelectronic Graded Neurons...

 June 28, 2023 | News

Prenetics and Prof. Dennis Lo Launch US$200m Joint Venture "Insighta" for Multi-Cancer Early Detection

- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. - Insighta is powered by technology developed by the Centre for Novostics w...

 June 26, 2023 | News

Brii Biosciences to Sell Equity Interest in Qpex Biopharma and Acquire Global Rights for BRII-693

Company acquires exclusive global rights of the novel lipopeptide BRII-693 for the difficult to treat MDR/XDR gram-negative bacterial infections &nbs...

 June 26, 2023 | News

Sirnaomics Advances STP705 for SCCIS into Late-Stage Clinical Development

The FDA provided Sirnaomics guidance to move forward with late-stage clinical development because of the efficacious data provided as well as the widesprea...

 June 20, 2023 | News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in